Product overview

Name iso-PPADS tetrasodium salt
Description Non-selective purinergic P2X receptor antagonist
Write Your Own Review
You're reviewing:iso-PPADS tetrasodium salt
Rate this item:

Biological Data

Biological description

iso-PPADS is a non-selective purinergic P2X receptor antagonist (pKi = 6.5).

It potently inhibits P2X1 and P2X3 receptors (IC50 values are 43 and 84 nM respectively). iso-PPADs is more potent than PPADs at P2X1, P2X2, P2X3 and P2Y1 receptors.


iso-PPADS exhibits similarly activity to PPADS.

Solubility & Handling

Storage instructions -20°C
Solubility overview Soluble in water (100 mM)
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Chemical name Pyridoxalphosphate-6-azophenyl-2',5'-disulfonic acid tetrasodium salt
Molecular Weight 599.3
Chemical structure iso-PPADS [207572-67-6] Chemical Structure
Molecular Formula C14H10N3Na4O12PS2
CAS Number 207572-67-6
PubChem identifier 57369506
SMILES CC1=NC(=NNC2=C(C=CC(=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])C(=C(C1=O)C=O)COP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+]
Source Synthetic
InChi InChI=1S/C14H14N3O12PS2.4Na/c1-7-13(19)9(5-18)10(6-29-30(20,21)22)14(15-7)17-16-11-4-8(31(23,24)25)2-3-12(11)32(26,27)28;;;;/h2-5,16H,6H2,1H3,(H2,20,21,22)(H,23,24,25)(H,26,27,28);;;;/q;4*+1/p-4
InChiKey MNDLDXSGNAXMPP-UHFFFAOYSA-J
Appearance Orange solid

References for iso-PPADS tetrasodium salt

References are publications that support the biological activity of the product
  • Actions of a Series of PPADS Analogs at P2X1 and P2X3 Receptors.

    Brown et al (2001) Drug Dev Res. 53(4) : 281-291
  • Differentiation by pyridoxal 5-phosphate, PPADS and IsoPPADS between responses mediated by UTP and those evoked by alpha, beta-methylene-ATP on rat sympathetic ganglia.

    Connolly GP (1995) Br J Pharmacol 114(3) : 727-31
  • Estimates of antagonist affinities at P2X purinoceptors in rat vas deferens.

    Khakh et al (1994) Eur J Pharmacol 263(3) : 301-9

3 Item(s)